Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -99.49x is 13% below its 5-year average of -88.37x, near the high end of its 5-year range (-1178.09x–-1.88x).
1.33% above its 12-month average of -100.83x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -76.27x.
INTEREST COVERAGE RATIO
-99.49x
INTEREST COVERAGE RATIO AVG TTM
-100.83x
INTEREST COVERAGE RATIO AVG 3Y
-180.75x
INTEREST COVERAGE RATIO AVG 5Y
-88.37x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+1.33%
CURRENT VS 3Y AVG
+44.96%
CURRENT VS 5Y AVG
-12.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 516 covered companies
CURRENT VS SECTOR MEDIAN
-1460.63%
vs the sector median at left
Oculis Holding AG
Market Cap
$496.23M
Interest Coverage Ratio
-99.49x
TTM Avg
-100.83x
3Y Avg
-180.75x
5Y Avg
-88.37x
Market Cap
$500.41M
Interest Coverage Ratio
28.21x
TTM Avg
19.43x
3Y Avg
14.40x
5Y Avg
14.40x
Market Cap
$507.34M
Interest Coverage Ratio
-192.50x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$507.94M
Interest Coverage Ratio
-69.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$485.33M
Interest Coverage Ratio
5.63x
TTM Avg
4.06x
3Y Avg
3.16x
5Y Avg
2.54x
Market Cap
$517.30M
Interest Coverage Ratio
-57.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $496.23M | -99.49x | -100.83x | -180.75x | -88.37x |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.41M | 28.21x | 19.43x | 14.40x | 14.40x |
| Allogene Therapeutics, Inc. (ALLO)vs › | $507.34M | -192.50x | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $507.94M | -69.85x | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.65M | -1.91x | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $485.33M | 5.63x | 4.06x | 3.16x | 2.54x |
| 908 Devices Inc. (MASS)vs › | $510.38M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $517.30M | -57.76x | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $475.51M | N/A | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $475.26M | N/A | N/A | N/A | N/A |
Interest Coverage
-99.5x
Debt/Equity
0.01
Current Ratio
8.35
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -76.27x |
| 2026-03-31 | -126.80x |
| 2025-12-31 | -87.32x |
| 2025-09-30 | -100.26x |
| 2025-06-30 | -113.49x |
| 2025-03-31 | -80.87x |
| 2024-12-31 | -70.16x |
| 2024-09-30 | -68.68x |
| 2024-06-30 | -258.45x |
| 2024-03-31 | -373.85x |
| 2023-12-31 | -1015.33x |
| 2023-09-30 | -1178.09x |
| 2023-06-30 | -632.06x |
| 2023-03-31 | -35.05x |
| 2022-12-31 | -8.40x |
| 2022-09-30 | -3.75x |
| 2022-06-30 | -5.55x |
| 2021-12-31 | -3.07x |
| 2021-09-30 | -1.88x |
